November 14, 2016
(Deutsche Welle) – Germany’s lower house of parliament, the Bundestag, on Friday passed a law changing the conditions researchers must meet to conduct clinical research on dementia patients. Previously, doctors were only permitted to test new medication to specifically treat patients themselves. Under the new framework, doctors can test a wider array of medicinal products that may not be catered to current patients but are rather designed to treat future patients.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.